title: Reply to W.A.A. Tjalma and J.S. Grossman.
authors: Division of Gynecologic Oncology, University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ bradley.monk@chw.edu.
authors: Bradley J
authors: BJ
authors: Monk
authors: Division of Gynecologic Oncology, UT Southwestern Medical Center at Dallas, Dallas, TX.
authors: David S
authors: DS
authors: Miller
authors: Division of Gynecologic Oncology, University of California, Irvine Medical Center, Orange, CA.
authors: Krishnansu S
authors: KS
authors: Tewari
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000628:therapy*